O'Shaughnessy Asset Management, LLC Editas Medicine, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$26.55 - $40.57 $98,341 - $150,271	-3,704 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$39.27 - $72.94 $7,696 - $14,296	-196 Reduced 5.03%	3,704 $152,000
Q1 2021 May 14, 2021	BUY	$39.71 - $90.58 $154,869 - $353,262	3,900 New	3,900 $164,000
Q1 2020 May 13, 2020	SELL	$14.88 - $32.78 $2,395 - $5,277	-161 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$19.49 - $32.63 $3,137 - $5,253	161 New	161 $5,000

240

56.5M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $85.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.